Neurological comorbidity and epilepsy: implications for treatment

被引:31
作者
Zaccara, G. [1 ]
机构
[1] Palagi Hosp, Neurol Unit, I-50125 Florence, Italy
来源
ACTA NEUROLOGICA SCANDINAVICA | 2009年 / 120卷 / 01期
关键词
antiepileptic drugs; co-morbidity; drug interactions; epilepsy; LONG-TERM TREATMENT; SERUM-LIPID LEVELS; ANTIEPILEPTIC DRUGS; OPTIMIZING THERAPY; BRAIN-TUMOR; OPEN-LABEL; UNPROVOKED SEIZURES; REFRACTORY EPILEPSY; VALPROIC ACID; DOUBLE-BLIND;
D O I
10.1111/j.1600-0404.2008.01146.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Epilepsy is a chronic condition that may be associated with several other diseases. In these cases, we should consider the following points: (1) antiepileptic drug (AED) treatment may positively or negatively affect comorbid disease, (2) drugs used for treatment of co-morbid disease may influence seizure threshold, (3) AED toxicity can be affected by a comorbid condition and (4) co-administration of AEDs with drugs used for treatment of comorbid conditions can be associated with clinically relevant drug-drug interactions. In this article, we discuss problems that are usually encountered when an appropriate AED treatment has to be selected in newly diagnosed epileptic patients who also have (an)other neurological disease(s). Comorbidity of epilepsy with cerebrovascular diseases, dementias, mental retardation, attention deficit and hyperactivity disorder, brain tumours, infections of the CNS, migraine, sleep disturbances (obstructive sleep apnoea syndrome), substance abuse and multiple sclerosis is discussed.
引用
收藏
页码:1 / 15
页数:15
相关论文
共 114 条
[1]   Optimizing therapy of seizures in children and adolescents with ADHD [J].
Aldenkamp, Albert P. ;
Arzimanoglou, Alexis ;
Reijs, Rianne ;
Van Mil, Saskia .
NEUROLOGY, 2006, 67 (12) :S49-S51
[2]   Gabapentin in late-onset poststroke seizures [J].
Alvarez-Sabín, J ;
Montaner, J ;
Padró, L ;
Molina, CA ;
Rovira, R ;
Codina, A ;
Quintana, R .
NEUROLOGY, 2002, 59 (12) :1991-1993
[3]  
Andermann E, 1987, MIGRAINE EPILEPSY, P281
[4]   Epilepsy and HIV-a dangerous combination [J].
不详 .
LANCET NEUROLOGY, 2007, 6 (09) :747-747
[5]   Antiepileptic drugs as independent predictors of plasma total homocysteine levels [J].
Apeland, T ;
Mansoor, MA ;
Strandjord, RE .
EPILEPSY RESEARCH, 2001, 47 (1-2) :27-35
[6]   Topiramate in long-term treatment of epilepsy in the intellectually disabled [J].
Arvio, M ;
Sillanpää, M .
JOURNAL OF INTELLECTUAL DISABILITY RESEARCH, 2005, 49 :183-189
[7]   Protease inhibitors in patients with HIV disease - Clinically important pharmacokinetic considerations [J].
Barry, M ;
Gibbons, S ;
Back, D ;
Mulcahy, F .
CLINICAL PHARMACOKINETICS, 1997, 32 (03) :194-209
[8]   Levetiracetam monotherapy in Alzheimer patients with late-onset seizures: a prospective observational study [J].
Belcastro, V. ;
Costa, C. ;
Galletti, F. ;
Pisani, F. ;
Calabresi, P. ;
Parnetti, L. .
EUROPEAN JOURNAL OF NEUROLOGY, 2007, 14 (10) :1176-1178
[9]   CPAP - A treatment for epilepsy? [J].
Benbadis, Selim R. ;
Liu, Lynn .
NEUROLOGY, 2007, 69 (19) :1814-1815
[10]   Optimizing therapy of seizures in patients with HIV and cysticercosis [J].
Bhigjee, A. I. ;
Rosemberg, S. .
NEUROLOGY, 2006, 67 (12) :S19-S22